Amanote Research

Amanote Research

    RegisterSign In

Treatment Options for High-Risk Chronic Lymphocytic Leukaemia

Therapeutic Advances in Hematology - United States
doi 10.1177/2040620711404469
Full Text
Open PDF
Abstract

Available in full text

Categories
Hematology
Date

May 4, 2011

Authors
Saman HewamanaClaire Dearden
Publisher

SAGE Publications


Related search

Chronic Lymphocytic Leukaemia

Nature Reviews Disease Primers
Medicine
2017English

161 Night-Shift Work and Chronic Lymphocytic Leukaemia Risk

Occupational and Environmental Medicine
EnvironmentalPublic HealthOccupational Health
2013English

Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2016English

Analysis of Treatment Options for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Tumour Lysis Syndrome After Treatment of Chronic Lymphocytic Leukaemia With Fludarabine.

Postgraduate Medical Journal
Medicine
1994English

Acute Renal Failure With Chronic Lymphocytic Leukaemia.

Postgraduate Medical Journal
Medicine
1996English

Stomach Cancer in a Patient With Chronic Lymphocytic Leukaemia

Creative surgery and oncology
2019English

The Prognostic Significance of Cytopenia in Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma

British Journal of Haematology
Hematology
2008English

Chronic Lymphocytic Leukaemia Genomics and the Precision Medicine Era

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy